These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26343367)

  • 61. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
    Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
    J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.
    Kaczmarek Michaels K; Wolschendorf F; Schiralli Lester GM; Natarajan M; Kutsch O; Henderson AJ
    Virology; 2015 Dec; 486():7-14. PubMed ID: 26379089
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch.
    Venkatachari NJ; Zerbato JM; Jain S; Mancini AE; Chattopadhyay A; Sluis-Cremer N; Bar-Joseph Z; Ayyavoo V
    Retrovirology; 2015 Oct; 12():85. PubMed ID: 26438393
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.
    Badia R; Grau J; Riveira-Muñoz E; Ballana E; Giannini G; Esté JA
    Antiviral Res; 2015 Nov; 123():62-9. PubMed ID: 26348004
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
    Moody MA; Gao F; Gurley TC; Amos JD; Kumar A; Hora B; Marshall DJ; Whitesides JF; Xia SM; Parks R; Lloyd KE; Hwang KK; Lu X; Bonsignori M; Finzi A; Vandergrift NA; Alam SM; Ferrari G; Shen X; Tomaras GD; Kamanga G; Cohen MS; Sam NE; Kapiga S; Gray ES; Tumba NL; Morris L; Zolla-Pazner S; Gorny MK; Mascola JR; Hahn BH; Shaw GM; Sodroski JG; Liao HX; Montefiori DC; Hraber PT; Korber BT; Haynes BF
    Cell Host Microbe; 2015 Sep; 18(3):354-62. PubMed ID: 26355218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of TRIM5α in vivo.
    Nakayama EE; Shioda T
    AIDS; 2015 Sep; 29(14):1733-43. PubMed ID: 26372380
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity.
    Rom S; Reichenbach NL; Dykstra H; Persidsky Y
    Front Microbiol; 2015; 6():878. PubMed ID: 26379653
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CRISPR-mediated Activation of Latent HIV-1 Expression.
    Limsirichai P; Gaj T; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):499-507. PubMed ID: 26607397
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
    Yu J; Li M; Wilkins J; Ding S; Swartz TH; Esposito AM; Zheng YM; Freed EO; Liang C; Chen BK; Liu SL
    Cell Rep; 2015 Oct; 13(1):145-156. PubMed ID: 26387945
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.
    Procopio FA; Fromentin R; Kulpa DA; Brehm JH; Bebin AG; Strain MC; Richman DD; O'Doherty U; Palmer S; Hecht FM; Hoh R; Barnard RJ; Miller MD; Hazuda DJ; Deeks SG; Sékaly RP; Chomont N
    EBioMedicine; 2015 Aug; 2(8):874-83. PubMed ID: 26425694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.
    Carlin E; Greer B; Lowman K; Duverger A; Wagner F; Moylan D; Dalecki A; Samuel S; Perez M; Sabbaj S; Kutsch O
    PLoS Pathog; 2021 Jan; 17(1):e1008748. PubMed ID: 33465149
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.
    Seu L; Tidwell C; Timares L; Duverger A; Wagner FH; Goepfert PA; Westfall AO; Sabbaj S; Kutsch O
    J Immunol; 2017 Nov; 199(9):3336-3347. PubMed ID: 28954890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.
    Sun J; Schaaf K; Duverger A; Wolschendorf F; Speer A; Wagner F; Niederweis M; Kutsch O
    Oncotarget; 2016 Mar; 7(13):15394-409. PubMed ID: 27004401
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exosomes in Viral Disease.
    Anderson MR; Kashanchi F; Jacobson S
    Neurotherapeutics; 2016 Jul; 13(3):535-46. PubMed ID: 27324390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.
    Dalecki AG; Greer BD; Duverger A; Strange EL; Carlin E; Wagner F; Shi B; Lowman KE; Perez M; Tidwell C; Kaczmarek Michaels K; Giattina S; Bossmann SH; Henderson AJ; Hu H; Kutsch O
    J Virol; 2022 Mar; 96(5):e0197421. PubMed ID: 35019721
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discovery of candidate HIV-1 latency biomarkers using an OMICs approach.
    Belshan M; Holbrook A; George JW; Durant HE; Callahan M; Jaquet S; West JT; Siedlik J; Ciborowski P
    Virology; 2021 Jun; 558():86-95. PubMed ID: 33735754
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The host cell side of latent HIV-1 infection.
    Seu L; Kutsch O
    Oncotarget; 2015 Aug; 6(24):19920-1. PubMed ID: 26343367
    [No Abstract]   [Full Text] [Related]  

  • 79. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
    Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
    J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.